Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A W Te Boekhorst

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Advances in Hematology|March 9, 2012
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative NeoplasmsMar Bellido, Peter A W Te Boekhorst
Blood|October 13, 2018
Patchy hematopoiesis mimicking bone metastasisA C Cornelisse, Peter A W Te Boekhorst
British Journal of Haematology|September 17, 2013
Hepatosplenic T-cell lymphomaPeter A W te Boekhorst, Kirsten van Lom
Haematologica|September 25, 2025
Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosisRuben Van Dijck, John-John B Schnog, Peter A W Te Boekhorst
The New England Journal of Medicine|December 14, 2011
Thrombopoietin-receptor agonists for immune thrombocytopeniaA J Gerard Jansen, Reinout M Swart, Peter A W te Boekhorst
Leukemia|August 7, 2021
Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001-2018Tom S M Posthuma, Otto Visser, Peter A W Te Boekhorst, et al.
Hemasphere|July 8, 2021
Survival in Primary Myelofibrosis: A Population-based Analysis in the NetherlandsStefanie Slot, Avinash G Dinmohamed, Otto Visser, et al.
Frontiers in Oncology|August 27, 2019
New Approaches and Treatment Combinations for the Management of Chronic Myeloid LeukemiaPeter E Westerweel, Peter A W Te Boekhorst, Mark-David Levin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2021
Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case seriesF Nanne Croles, Peter A W Te Boekhorst, Frank W G Leebeek, et al.
British Journal of Haematology|October 21, 2024
Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpuraA J Gerard Jansen, Minke A E Rab, Peter A W Te Boekhorst, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Advances in Hematology|March 9, 2012
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative NeoplasmsMar Bellido, Peter A W Te Boekhorst
Blood|October 13, 2018
Patchy hematopoiesis mimicking bone metastasisA C Cornelisse, Peter A W Te Boekhorst
British Journal of Haematology|September 17, 2013
Hepatosplenic T-cell lymphomaPeter A W te Boekhorst, Kirsten van Lom
Haematologica|September 25, 2025
Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosisRuben Van Dijck, John-John B Schnog, Peter A W Te Boekhorst
The New England Journal of Medicine|December 14, 2011
Thrombopoietin-receptor agonists for immune thrombocytopeniaA J Gerard Jansen, Reinout M Swart, Peter A W te Boekhorst
Leukemia|August 7, 2021
Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001-2018Tom S M Posthuma, Otto Visser, Peter A W Te Boekhorst, et al.
Hemasphere|July 8, 2021
Survival in Primary Myelofibrosis: A Population-based Analysis in the NetherlandsStefanie Slot, Avinash G Dinmohamed, Otto Visser, et al.
Frontiers in Oncology|August 27, 2019
New Approaches and Treatment Combinations for the Management of Chronic Myeloid LeukemiaPeter E Westerweel, Peter A W Te Boekhorst, Mark-David Levin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2021
Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case seriesF Nanne Croles, Peter A W Te Boekhorst, Frank W G Leebeek, et al.
British Journal of Haematology|October 21, 2024
Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpuraA J Gerard Jansen, Minke A E Rab, Peter A W Te Boekhorst, et al.
Pageof 4